$SFES
SAFEGUARD SCIENTIFICS INC

2020 Q1 Form 10-Q Financial Statement

#000143774920009020 Filed on April 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.800M $3.100M
YoY Change -41.94% -44.64%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.800M $3.100M
YoY Change -41.94% -44.64%
Operating Profit -$3.532M -$3.057M
YoY Change 15.54% -45.3%
Interest Expense -$2.700M $26.60M
YoY Change -110.15% 2855.56%
% of Operating Profit
Other Income/Expense, Net -$3.567M -$1.885M
YoY Change 89.23% 31.36%
Pretax Income -$16.01M $21.66M
YoY Change -173.9% -451.1%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$16.01M $21.66M
YoY Change -173.9% -451.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.77 $1.05
Diluted Earnings Per Share -$0.77 $1.05
COMMON SHARES
Basic Shares Outstanding 20.69M 20.59M
Diluted Shares Outstanding 20.69M 20.59M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.90M $77.79M
YoY Change -73.13% 126.84%
Cash & Equivalents $20.93M $44.59M
Short-Term Investments $33.20M
Other Short-Term Assets $600.0K $3.900M
YoY Change -84.62% 34.48%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $21.59M $81.71M
YoY Change -73.57% 119.68%
LONG-TERM ASSETS
Property, Plant & Equipment $2.026M $2.430M
YoY Change -16.63% 69.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $29.56M $48.73M
YoY Change -39.34% -50.95%
Other Assets $1.992M $712.0K
YoY Change 179.78% 125.32%
Total Long-Term Assets $70.82M $88.75M
YoY Change -20.2% -33.79%
TOTAL ASSETS
Total Short-Term Assets $21.59M $81.71M
Total Long-Term Assets $70.82M $88.75M
Total Assets $92.41M $170.5M
YoY Change -45.79% -0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $141.0K $110.0K
YoY Change 28.18% -53.59%
Accrued Expenses $568.0K $2.170M
YoY Change -73.82% -24.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $72.80M
YoY Change 78.43%
Total Short-Term Liabilities $3.185M $76.94M
YoY Change -95.86% 66.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.112M $2.039M
YoY Change -45.46% -38.97%
Total Long-Term Liabilities $1.112M $2.039M
YoY Change -45.46% -38.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.185M $76.94M
Total Long-Term Liabilities $1.112M $2.039M
Total Liabilities $6.600M $81.57M
YoY Change -91.91% -14.48%
SHAREHOLDERS EQUITY
Retained Earnings -$713.2M -$709.4M
YoY Change 0.53% -1.69%
Common Stock $813.0M $813.5M
YoY Change -0.06% -0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.92M $15.16M
YoY Change -8.16% -13.1%
Treasury Stock Shares $924.0K 998.0K shares
Shareholders Equity $85.80M $88.90M
YoY Change
Total Liabilities & Shareholders Equity $92.41M $170.5M
YoY Change -45.79% -0.45%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$16.01M $21.66M
YoY Change -173.9% -451.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.551M -$5.782M
YoY Change -55.88% -14.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.500M $42.80M
YoY Change -103.5% 285.59%
Cash From Investing Activities -$1.533M $42.85M
YoY Change -103.58% 284.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$11.00K -149.0K
YoY Change -92.62% -0.67%
NET CHANGE
Cash From Operating Activities -$2.551M -5.782M
Cash From Investing Activities -$1.533M 42.85M
Cash From Financing Activities -$11.00K -149.0K
Net Change In Cash -$4.095M 36.91M
YoY Change -111.09% 777.44%
FREE CASH FLOW
Cash From Operating Activities -$2.551M -$5.782M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000086115
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20673078
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
SAFEGUARD SCIENTIFICS INC
CY2020Q1 sef Employee And Severance Agreement Maximum Aggregate Exposure
EmployeeAndSeveranceAgreementMaximumAggregateExposure
2200000
CY2020Q1 sef Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
619000
CY2020Q1 sef Lessee Sublease Expected Receipts Total
LesseeSubleaseExpectedReceiptsTotal
3367000
CY2020Q1 sef Lessee Subleaseexpected Receipts Remainder Of Fiscal Year
LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear
384000
CY2020Q1 sef Lessee Subleaseexpected Receipts Thereafter
LesseeSubleaseexpectedReceiptsThereafter
199000
CY2020Q1 sef Lessee Subleaseexpected Receipts Year Five
LesseeSubleaseexpectedReceiptsYearFive
573000
CY2020Q1 sef Lessee Subleaseexpected Receipts Year Four
LesseeSubleaseexpectedReceiptsYearFour
556000
CY2020Q1 sef Lessee Subleaseexpected Receipts Year Six
LesseeSubleaseexpectedReceiptsYearSix
590000
CY2020Q1 sef Lessee Subleaseexpected Receipts Year Three
LesseeSubleaseexpectedReceiptsYearThree
540000
CY2020Q1 sef Lessee Subleaseexpected Receipts Year Two
LesseeSubleaseexpectedReceiptsYearTwo
525000
CY2020Q1 sef Number Of Non Consolidated Partner Companies
NumberOfNonConsolidatedPartnerCompanies
13
CY2020Q1 sef Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments
OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments
CY2019Q1 sef Other Comprehensive Income Loss Share Of Other Comprehensive Income Loss Of Equity Method Investments
OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments
-31000
CY2019Q1 sef Preferred Stock Purchase Right To Be Exchanged For Common Stock Above Maximum Ownership Threshold
PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold
1
CY2019Q1 sef Sale Of Stock Individual Ownership Percent Maximum
SaleOfStockIndividualOwnershipPercentMaximum
0.0499
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 sef Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
72000
CY2019Q1 sef Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
-149000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
141000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
39000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
568000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
627000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
810827000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
810856000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
417000
CY2020Q1 us-gaap Advances To Affiliate
AdvancesToAffiliate
13321000
CY2019Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
15103000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
86000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
417000
CY2020Q1 us-gaap Assets
Assets
92408000
CY2019Q4 us-gaap Assets
Assets
107577000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
21592000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
26350000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20933000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25028000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25053000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8203000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20958000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45117000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4095000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
36914000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2157000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2157000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-16008000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
21632000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3532000
CY2020Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
800000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2096000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1364000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
29560000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
34542000
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1500000
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
23917000
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
27484000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3532000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3057000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16008000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21663000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9014000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
28267000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-31000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
CY2019Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
2535000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
105000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
873000
CY2020Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
66798000
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
77129000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3772000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
207000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
613000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
607000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
601000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
595000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
530000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1089000
CY2020Q1 us-gaap Liabilities
Liabilities
6600000
CY2019Q4 us-gaap Liabilities
Liabilities
5836000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92408000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
107577000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3185000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2429000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-149000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1533000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
42845000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2551000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5782000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1112000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1997000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3057000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2683000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
380000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
399000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2303000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2380000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1992000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1027000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3567000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1885000
CY2020Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
1241000
CY2019Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
3925000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
149000
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
CY2020Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
CY2019Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
57243000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
634000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1297000
CY2020Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
708000
CY2019Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
41778000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
62235000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16008000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
21663000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2026000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2101000
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-713231000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-697223000
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
7000
CY2019Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85808000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101741000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
66979000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
88879000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
924000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
930000
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
13920000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
14024000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20686000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20585000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20686000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20585000

Files In Submission

Name View Source Status
0001437749-20-009020-index-headers.html Edgar Link pending
0001437749-20-009020-index.html Edgar Link pending
0001437749-20-009020.txt Edgar Link pending
0001437749-20-009020-xbrl.zip Edgar Link pending
ex_179566.htm Edgar Link pending
ex_179567.htm Edgar Link pending
ex_179568.htm Edgar Link pending
ex_179569.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sef-20200331.xml Edgar Link completed
sef-20200331.xsd Edgar Link pending
sef-20200331_cal.xml Edgar Link unprocessable
sef-20200331_def.xml Edgar Link unprocessable
sef-20200331_lab.xml Edgar Link unprocessable
sef-20200331_pre.xml Edgar Link unprocessable
sfe20200303_10q.htm Edgar Link pending
Show.js Edgar Link pending